True North Advisors, LLC Abbott Laboratories Transaction History

True North Advisors, LLC

$378 Million
Q3 2024

A detailed history of True North Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, True North Advisors, LLC holds 7,947 shares of ABT stock, worth $931,865. This represents 0.24% of its overall portfolio holdings.

Number of Shares

7,947

Previous 7,749 2.56%

Holding current value

$931,865

Previous $805,000 12.55%

% of portfolio

0.24%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$100.07 - $118.13 $19,813 - $23,389	198 Added 2.56%	7,947 $906,000
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $27,600 - $30,808	-274 Reduced 3.42%	7,749 $805,000
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $736,302 - $813,214	-6,723 Reduced 45.59%	8,023 $911,000
Q4 2023 Jan 22, 2024	SELL	$90.19 - $110.4 $76,210 - $93,288	-845 Reduced 5.42%	14,746 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $25,984 - $31,176	272 Added 1.78%	15,591 $1.51 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $316,549 - $352,702	3,141 Added 25.79%	15,319 $1.67 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $65,283 - $76,842	-674 Reduced 5.24%	12,178 $1.23 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $48,955 - $57,432	-515 Reduced 3.85%	12,852 $1.41 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $5,321 - $6,161	55 Added 0.41%	13,367 $1.29 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $39,194 - $47,374	384 Added 2.97%	13,312 $1.45 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $2.24 Million - $2.73 Million	-19,669 Reduced 60.34%	12,928 $1.53 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $64,696 - $79,217	-560 Reduced 1.69%	32,597 $4.59 Million
Q3 2021 Jun 07, 2022	SELL	$116.66 - $129.06 $82,361 - $91,116	-706 Reduced 2.08%	33,157 $3.92 Million
Q2 2021 Jun 07, 2022	SELL	$105.79 - $124.53 $34,487 - $40,596	-326 Reduced 0.95%	33,863 $3.93 Million
Q1 2021 Jun 07, 2022	BUY	$108.84 - $128.23 $21,768 - $25,645	200 Added 0.59%	34,189 $4.1 Million
Q4 2020 May 20, 2022	SELL	$105.0 - $114.42 $36,960 - $40,275	-352 Reduced 1.03%	33,989 $3.72 Million
Q3 2020 May 20, 2022	SELL	$91.64 - $111.29 $896,422 - $1.09 Million	-9,782 Reduced 22.17%	34,341 $3.74 Million
Q2 2020 May 20, 2022	SELL	$76.57 - $98.0 $6,431 - $8,232	-84 Reduced 0.19%	44,123 $4.03 Million
Q1 2020 May 12, 2022	SELL	$62.82 - $91.86 $33,483 - $48,961	-533 Reduced 1.19%	44,207 $3.49 Million
Q4 2019 May 12, 2022	BUY	$78.51 - $87.4 $3.51 Million - $3.91 Million	44,740 New	44,740 $3.89 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Account

True North Advisors, LLC Abbott Laboratories Transaction History